Zinc and Iron in Children With Short Stature
zincandiron
1 other identifier
observational
50
1 country
1
Brief Summary
Short stature is defined as height below 3rd centile or less than two standard deviations below the median height for that age and sex according to the population standard zinc and iron have important role in growth for children
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2017
CompletedFirst Posted
Study publicly available on registry
April 27, 2017
CompletedStudy Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2019
CompletedOctober 30, 2020
October 1, 2020
7 months
April 23, 2017
October 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
zinc and iron in children with idiopathic short stature
Assessment of the serum level of zinc and iron in idiopathic with short stature.
6 months
Study Arms (2)
column heading in tables
history examinations investigation:serum zinc and iron
row heading in tables
history examinations investigation:serum zinc and iron
Interventions
history ,examination,investigations
Eligibility Criteria
50 cases will be included :35 child with idiopathic short stature and 25 as controls aging from4-18 years old coming to endocrinology clinic at Assuit University Children Hospital will be investigated for serum of zinc and iron
You may qualify if:
- children of both sexes.
- Age range: 4-18 years.
- patients fulfilling criteria of short stature.
- height is 2 standard deviations below normal .
- initial height below the third percentile on Egyptian growth chart. • Number of patients: will include 50 cases
You may not qualify if:
- Skeletal dysplasia.
- Chromosomal anomalies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Engy dawood
Asiut, Egypt
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
April 23, 2017
First Posted
April 27, 2017
Study Start
June 1, 2017
Primary Completion
January 1, 2018
Study Completion
August 15, 2019
Last Updated
October 30, 2020
Record last verified: 2020-10